Scilex Holding Co (SCLX)
0.9806
+0.12
(+14.14%)
USD |
NASDAQ |
Oct 04, 16:00
0.9669
-0.01
(-1.40%)
After-Hours: 20:00
Scilex SG&A Expense (TTM): 117.83M for June 30, 2024
SG&A Expense (TTM) Chart
Historical SG&A Expense (TTM) Data
Date | Value |
---|---|
June 30, 2024 | 117.83M |
March 31, 2024 | 120.22M |
December 31, 2023 | 119.64M |
September 30, 2023 | 119.64M |
Date | Value |
---|---|
June 30, 2023 | 95.33M |
March 31, 2023 | 82.69M |
December 31, 2022 | 64.90M |
SG&A Expense Definition
SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.
SG&A Expense (TTM) Range, Past 5 Years
64.90M
Minimum
Dec 2022
120.22M
Maximum
Mar 2024
102.89M
Average
117.83M
Median
Jun 2024
SG&A Expense (TTM) Benchmarks
Masimo Corp | 653.40M |
Oramed Pharmaceuticals Inc | 7.523M |
Perspective Therapeutics Inc | 18.64M |
Electromed Inc | 34.49M |
Xtant Medical Holdings Inc | 79.82M |